Dallas developer Lincoln Property Co., alongside investor Federal Capital Partners, is planning a large new office, research and development, and light-manufacturing campus in Broomfield’s Interlocken business park, with the aim of attracting life-sciences industry tenants.
The project, known as CoRE — Colorado Research Exchange, will be built at 235 Interlocken Blvd. and is planned to total about 450,000 square feet spread across four buildings that will range from about 16,000 square feet for the development’s amenities center to nearly 200,000 square feet for the largest office building.
“Our purpose-built campus will include tenant spaces designed specifically to accommodate lab/life science or tech uses,” Lincoln senior vice president Scott Caldwell said in a statement. “Companies won’t need to rehabilitate or convert old office or industrial space; these facilities will be on the cutting edge of critical environments for a broad range of uses.”
The buildings will be between two and five stories.
“The developer has described the diagram of the site as keeping pedestrians at the center, then buildings, then service and a ring road, followed by surface parking along the perimeter of the site,” according to planning documents. “They have noted that the building orientation reinforces views to the mountains and aims to minimize solar glare and natural heat gain on the western facades.”
Plans call for a garage with five parking levels that will have a capacity for approximately 900 vehicles, according to Broomfield planning documents.
Amenities are expected to include a fitness center, locker rooms, bike storage, a tenant lounge with fireplace, an outdoor terrace, a conference/training facility and a food market.
Architecture firm HKS Inc. is designing CoRE, and CBRE staffers will serve as the project’s leasing agents.
“FCP is excited to partner with Lincoln Property Company, a leader in life science development, to deliver an amenity-rich and sustainable commercial environment to meet the strong demand for life science space in the Denver/Boulder market,” FCP senior vice president Liz Koteles said in a statement.
CoRE is the latest example of the Boulder Valley’s emergence as a world leader in biotechnology.
Part of the regional biotech emergence has involved developers committing to building office and lab space specifically tailored to the needs of life-sciences companies. For example, Boulder developer Conscience Bay Co. LLC is in the process of planning West Meadows, a 112,423-square-foot, biotech-focused project at 3825 Walnut St. in Boulder.
“I envision us climbing to a top five leading life sciences hub,” Colorado Bioscience Association CEO Elyse Blazevich said during a BizWest CEO Roundtable last month.
CoRE is “currently in the second step of the development review process: formal review of the project,” according to Broomfield planners. “Staff and external reviewing agencies will review the development proposal and applicable documents and will work with the developer to revise and refine their development plans. Once the formal review of the project is completed, the project will move on to the third step of the process: public hearings.”
Assuming the project is approved by Broomfield City Council, Lincoln Property expects to begin construction in the fall with completion anticipated in 2024.
This article was first published by BizWest, an independent news organization, and is published under a license agreement. © 2022 BizWest Media LLC.